MARKET

SNY

SNY

Sanofi FR
NASDAQ
45.27
+1.27
+2.89%
Opening 10:05 07/28 EDT
OPEN
44.90
PREV CLOSE
44.00
HIGH
45.48
LOW
44.89
VOLUME
452.80K
TURNOVER
--
52 WEEK HIGH
49.91
52 WEEK LOW
40.89
MARKET CAP
109.33B
P/E (TTM)
21.55
1D
5D
1M
3M
1Y
5Y
1D
Sanofi Reshapes Executive Committee for Next Strategic Chapter
TipRanks · 1d ago
Sanofi names Jamie Haney general counsel in executive committee reshuffle
PUBT · 1d ago
Weekly Report: what happened at SNY last week (0720-0724)?
Weekly Report · 1d ago
Regeneron: I'm Not Concerned About The Declining ROIC And Operating Margins
Seeking Alpha · 3d ago
Sanofi Drops Dupixent Successor Candidate After Assessing Data
Benzinga · 3d ago
Eli Lilly and Sanofi-backed Scribe surges in public debut
Seeking Alpha · 3d ago
Sanofi Advances Real-World Asthma Study, Sharpening Its Long-Term Biologics Strategy
TipRanks · 3d ago
Sanofi Targets New Growth With Bioequivalence Study for REZUROCK Suspension
TipRanks · 3d ago
More
About SNY
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Webull offers Sanofi SA (ADR) stock information, including NASDAQ: SNY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNY stock methods without spending real money on the virtual paper trading platform.